Jpmorgan Chase & CO Medpace Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 175,239 shares of MEDP stock, worth $59.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175,239
Previous 162,784
7.65%
Holding current value
$59.2 Million
Previous $67 Million
12.83%
% of portfolio
0.0%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding MEDP
# of Institutions
618Shares Held
25.1MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$871 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$860 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$307 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$254 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$212 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.5B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...